you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

This report is for females of European ancestry, which does not match your settings for males of European ancestry. The results may therefore not be applicable for you.

Ovarian Cancer

Ovarian cancer can occur in one or both of the ovaries, the reproductive glands of women. This cancer develops silently and is often first detected after it has reached a stage where it can be difficult to treat. The greatest known risk factor for ovarian cancer is a family history of the disease.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity:  European ancestry

Gender:    Female


Ovca
According to the selected literature, the relative genetic risk calculated from your genotype for females of European ancestry is 1.13. This corresponds to a 1.6% lifetime risk of developing ovarian cancer, which is 13% greater than for females of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 16 of every 1000 females of European ancestry with your genotype variants develop this disease in their lifetime.
Ovca
The average lifetime risk
On average, about 14 of every 1000 females of European ancestry develop this disease in their lifetime.
Ovca

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Ovarian Cancer

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).